JAOA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


JAOA • Vol 104 • No 3_suppl_1 • March 2004 • 6-10
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelsey, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelsey, J. E.

Achieving Remission in Major Depressive Disorder: The First Step to Long-Term Recovery

Jeffrey E. Kelsey, MD, PhD

Dr Kelsey is medical director of the Georgia Institute of Mood and Anxiety Disorders in Atlanta.

Correspondence to Jeffrey E. Kelsey, MD, PhD, Medical Director, Georgia Institute of Mood and Anxiety Disorders, 7 Piedmont Center, Suite 300, 3525 Piedmont Rd, Atlanta, GA 30305-1537. E-mail: jekelsey{at}bellsouth.net

Major Depressive Disorder (MDD) is a common clinical condition encountered in primary care practices. Left untreated or, more commonly, undertreated, MDD typically results in significant distress and dysfunction. Successful treatment of MDD, usually defined as achieving sustained remission, is an attainable goal. As such, sustained remission should be the goal sought by physicians and patients. A number of variables have an impact on the likelihood of achieving and sustaining remission including the length of the depressive episode, the completeness of the response to treatment, and whether remission is achieved relatively early in treatment. The selection of pharmacotherapeutic agents and the relative probability of achieving remission has only recently been investigated in outpatient populations, though this issue has been explored in inpatient studies for more than a decade.

This article reviews these variables and presents strategies with the goal of achieving remission for patients with MDD. The importance of both pharmacotherapy, where indicated, as well as psychotherapy is discussed. Finally, remission is presented as a necessary first step to ensure an optimal long-term outcome, rather than as the final goal of treatment.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Osteopathic Association.